The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
Open accessAbstract
We determined whether resveratrol, a phenolic antioxidant found in grapes and other food products, inhibited phorbol ester (PMA)-mediated induction of COX-2 in human mammary and oral epithelial cells. Treatment of cells with PMA induces COX-2 and causes a marked increase in the production of prostaglandin E2. These effects were inhibited by resveratrol. Resveratrol suppressed PMA-mediated increases in COX-2 mRNA and protein. Nuclear run-offs revealed increased rates of COX-2 transcription after treatment with PMA, an effect that was inhibited by resveratrol. PMA caused about a 6-fold increase in COX-2 promoter activity, which was suppressed by resveratrol. Transient transfections utilizing COX-2 promoter deletion constructs and COX-2 promoter constructs, in which specific enhancer elements were mutagenized, indicated that the effects of PMA and resveratrol were mediated via a cyclic AMP response element. Resveratrol inhibited PMA-mediated activation of protein kinase C. Overexpressing protein kinase C-alpha, ERK1, and c-Jun led to 4.7-, 5.1-, and 4-fold increases in COX-2 promoter activity, respectively. These effects also were inhibited by resveratrol. Resveratrol blocked PMA-dependent activation of AP-1-mediated gene expression. In addition to the above effects on gene expression, we found that resveratrol also directly inhibited the activity of COX-2. These data are likely to be important for understanding the anti-cancer and anti-inflammatory properties of resveratrol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Self-citationRapid colorimetric assay for cell growth and survival
Denizot, F., & Lang, R. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90368-6 · Cited by 4,935
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Gehm, B. D., McAndrews, J. M., Chien, P.-Y., & Jameson, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14138 · Cited by 1,063
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.
Kargman, S., O’Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., & Jothy, S. (1995) · PubMed · Cited by 824
Expression of cyclooxygenase-2 in human gastric carcinoma.
Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., & Härkönen, M. (1997) · PubMed · Cited by 813
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Inoue, H., Yokoyama, C., Hara, S., Tone, Y., & Tanabe, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24965 · Cited by 479
Self-citationKutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., & Prescott, S. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4816 · Cited by 449
Nuclear Receptor/AP-1 Interaction*
PFAHL, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-651 · Cited by 446
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah, K., TELANG, N. T., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., & Dannenberg, A. J. (1996) · PubMed · Cited by 418
Self-citationExpression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., & Seibert, K. (1995) · Biochemical Journal · doi:10.1042/bj3050479 · Cited by 412
Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells.
Huang, T. S., Lee, S. C., & Lin, J. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5292 · Cited by 374
DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., & Bishop, P. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116998 · Cited by 373
Rolland, P. H., Martin, P., Jacquemier, J. D., Rolland, A. M., & Toga, M. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/64.5.1061 · Cited by 348
Xie, W., & Herschman, H. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27622 · Cited by 288
Yoshioka, K., Deng, T., Cavigelli, M., & Karin, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4972 · Cited by 228
O'Brian, C. A., Vogel, V. G., Singletary, S. E., & Ward, N. E. (1989) · PubMed · Cited by 214
Difference in transcriptional regulatory function between c-Fos and Fra-2
Suzuki, T., Okuno, H., Yoshida, T., Endo, T., Nishina, H., & Iba, H. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5537 · Cited by 203
Inoue, H., Nanayama, T., Hara, S., Yokoyama, C., & Tanabe, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00731-4 · Cited by 186
Self-citationMESTRE, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., & Dannenberg, A. J. (1997) · PubMed · Cited by 155
Self-citationProstaglandins, their inhibitors and cancer
LUPULESCU, A. P. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90064-2 · Cited by 150
Müller‐Decker, K., Scholz, K., Marks, F., & Fürstenberger, G. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120106 · Cited by 146
In vitro -Hemmung der Prostaglandin-Biosynthese durch etherische Öle und phenolische Verbindungen
Wagner, H., Wierer, M., & Bauer, R. (1986) · Planta Medica · doi:10.1055/s-2007-969117 · Cited by 135
Sacks, P. G. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00049486 · Cited by 129
Zhai, Y. F., Beittenmiller, H. F., Wang, B., Gould, M. N., Oakley, C. S., Esselman, W. J., & Welsch, C. W. (1993) · PubMed · Cited by 114
Trejo, J., Massamiri, T., Deng, T., Dewji, N. N., Bayney, R. M., & Brown, J. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31860-4 · Cited by 105
Lee, S. F., & Lin, J. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514572 · Cited by 65
Cited by
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
Metadata
- Authors
- Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-08
- Volume
- 273
- Issue
- 34
- Pages
- 21875-21882
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989969820
- Cited by
- 786
- References
- 41
- FWCI
- 34.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.